A clinical trial of Baricitinib in Juvenile Dermatomyositis (BAR-JDM): comparing baricitinib and steroids to methotrexate and steroids over 52 weeks

Category Primary study
Registry of TrialsISRCTN registry
Year 2025
This article has no abstract
Epistemonikos ID: 8f6dfb7e10bdcb7ebda42fcaa72b0aa57f8cc61a
First added on: Jun 04, 2025